Investigation Overview
An investigation on behalf of current investors Javelin Pharmaceuticals Inc. (Public, AMEX:JAV), who purchased the JAV shares before December 18, 2009, over potential breaches of fiduciary duty and other violations of state law in connection with an alleged unfair takeover price was announced. The investigation by a law firm focus on potential breaches of fiduciary duty and other vio...
You must register (for free) or login to view the entire investigation.